Health Benefits of an Exercise Program for Adults With Arthritis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00146393|
Recruitment Status : Completed
First Posted : September 7, 2005
Last Update Posted : December 9, 2005
|Condition or disease||Intervention/treatment||Phase|
|Arthritis Osteoarthritis Rheumatoid Arthritis||Behavioral: People with Arthritis Can Exercise program||Phase 2 Phase 3|
Self-management is very important in chronic diseases, and promoting physical activity is a key public health strategy for arthritis management. Although several exercise programs such as People with Arthritis Can Exercise (PACE) have been created to implement this strategy, none have sufficient scientific evidence supporting their effectiveness to promote the programs through public health avenues.
The primary goal of this study is to assess the effect of PACE(People with Arthritis Can Exercise), a community-based group recreational exercise program, on key arthritis-related health outcomes. The primary goal of the study will be accomplished through an eight week randomized controlled trial conducted with 480 participants residing in eight urban or rural communities in North Carolina. This project is designed to evaluate the effectiveness of the program in changing arthritis-related health outcomes such as pain, function and physical activity levels. The project will compare the eight week PACE program to a control group.
The specific objectives are as follows: (The aims have not been modified.)
- To further review the PACE conceptual framework and materials in order to develop a standardized PACE protocol to be delivered in the study as well as to refine study measures.
- To work closely with the Carolinas AF Chapter to develop collaborative relationships with local health departments and key contacts in communities identified for PACE implementation.
- To recruit 480 individuals to participate in a randomized controlled trial of PACE in eight communities and to implement the PACE program.
- To compare changes in key arthritis-related health outcomes between PACE participants and controls over eight weeks (PACE course time frame).
- To determine longer-term benefits of the PACE intervention by examining key arthritis-related health outcomes 3 and 6 months post completion of the intervention.
- To conduct qualitative research among PACE completers and non-completers to determine motivators and barriers to success, as well as to determine the acceptability and suitability of the program.
- To formulate recommendations or modifications for implementation of the PACE program.
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||347 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Evaluation of People With Arthritis Can Exercise|
|Study Start Date :||July 2003|
|Estimated Study Completion Date :||June 2004|
- Visual Analog Scale pain level at baseline, 2, 3 and 6 months
- Self-reported physical function (Health Assessment Questionnaire) at baseline, and 2, 3 and 6 months
- Measured function (6 minute walk, 360 deg turn, walking speed and timed chair stands, 10 lb lift) at baseline and 2 months
- Physical activity level (Physical Activity Scale for the Elderly : PASE) at baseline, 2, 3 and 6 months
- Visual analog scale fatigue
- Visual analog scale stiffness
- Rheumatoid Arthritis Self-efficacy Scale (RASE)
- Center for Epidemiologic Studies Depression Scale (CES-D)
- Outcomes Expectations for Exercise (OEE)
- COnfidence Self-efficacy (CSE)
- Rheumatology Attitudes Index (RAI)
- Tampa Scale for Kinesiophobia (TSK)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00146393
|Study Chair:||Jennifer M Hootman, PhD||Centers for Disease Control and Prevention|
|Principal Investigator:||Leigh Callahan, PhD||University of North Carolina, Chapel Hill|